Quest Intl., Inc.

FDA Regulatory Profile

Quest Intl., Inc. appears in FDA public data with 0 recalls, 25 510(k) clearances, 0 FDA inspections, and 0 compliance actions on record. Its most recent 510(k) clearance was granted on Jun 8, 2009.

Summary

Total Recalls
0
510(k) Clearances
25
Inspections
0
Compliance Actions
0

Recent 510(k) Clearances

K-NumberDeviceDate
K091260SERAQUEST EBV EA-D IGG TESTJun 8, 2009
K033915MODIFICATION TO SERAQUEST EB VCA IGGJan 16, 2004
K033780MODIFICATION TO SERAQUEST VCA IGMJan 15, 2004
K023593SERAQUEST ANTI-THYROID PEROXIDASE (TPO)Feb 6, 2003
K023592SERAQUEST ANTI-THYROGLOBULINJan 6, 2003
K003069ANTI-CARDIOLIPIN, MULTIPLE AUTOANTIBODIES IMMUNOLOGICAL TEST SYSTEMNov 27, 2000
K991975SERAQUEST EB NA IGGNov 2, 1999
K990410SERAQUEST EB VCA IGGOct 28, 1999
K990977SERAQUEST EB VAC IGMOct 6, 1999
K982485SERAQUEST CMV IGMJan 13, 1999
K982281SERAQUEST RUBELLA IGMOct 16, 1998
K980540SERAQUEST ANTI-SMJun 15, 1998
K980639SERAQUEST ANTI-SSBJun 15, 1998
K980810SERAQUEST ANTI-SSAMay 12, 1998
K980811SERAQUEST ANTI-SM/RNPMay 12, 1998
K980391SERAQUEST ANTI-DSDNAApr 24, 1998
K980059SERAQUEST MUMPS IGGApr 23, 1998
K972295SERAQUEST VZV IGGNov 5, 1997
K971672SERAQUEST TOXOPLASMA IGMOct 21, 1997
K963282SERAQUEST HSV IGGJan 22, 1997